Shire CEO to Retire in 2013; Bayer’s Ornskov Gets Top Job

Shire Plc said Bayer AG’s Flemming Ornskov will take over as chief executive officer of the world’s biggest maker of attention-deficit disorder drugs, following the retirement of Angus Russell next year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.